Multimodal Analgesia in Major Abdominal Pediatric Cancer Surgeries

Sponsor
National Cancer Institute, Egypt (Other)
Overall Status
Completed
CT.gov ID
NCT03580980
Collaborator
(none)
90
1
3
32
2.8

Study Details

Study Description

Brief Summary

Surgical trauma initiates multiple physiological mechanisms that cause postoperative pain. Postoperative pain has nociceptive, inflammatory, and neuropathic components.Inadequate relief of postoperative pain leads to significant morbidity, delayed recovery, and mortality.Adverse reactions of medications used for postoperative pain management, particularly opioids, are common including pruritus and nausea and vomiting.Preemptive analgesia is defined as analgesic treatment that starts before surgical incision to prevent central sensitization caused by incisional and inflammatory injuries.Therefore, in this pilot study, the investigators are trying to evaluate safety and efficacy of preemptive multimodal analgesia compared with preemptive caudal analgesia and PCA morphine in pediatric cancer patient undergoing major abdominal surgery.

Condition or Disease Intervention/Treatment Phase
  • Drug: Paracetamol and ketamine
  • Procedure: Caudal levobupivacaine
  • Drug: Morphine
N/A

Detailed Description

Surgical trauma initiates multiple physiological mechanisms that cause postoperative pain. Postoperative pain has nociceptive, inflammatory, and neuropathic components.Inadequate relief of postoperative pain leads to significant morbidity, delayed recovery, and mortality.Despite the development of new drugs and analgesic techniques, up to 40% of hospitalized children - especially surgical patients - experiences moderate to severe pain. Adverse reactions of medications used for postoperative pain management, particularly opioids, are common including pruritus and nausea and vomiting.The incidence of opioid-related respiratory depression was reported to range from 0.11 to 0.41%.Regional anesthesia was suggested as an alternative to opioid-based analgesia in pediatric patients. Caudal epidural analgesia is a relatively safe and simple technique for postoperative pain management in children.However, there is a potential for adverse effects related to the technique of catheter placement or systemic toxicity of the local anesthetic.

Preemptive analgesia is defined as analgesic treatment that starts before surgical incision to prevent central sensitization caused by incisional and inflammatory injuries.However, studies in animal models of incisional pain demonstrated that single analgesic treatment before the incision does not reduce postoperative pain. Once nociceptive afferent block subsides, the wound reinitiates central sensitization. Also, clinical trials reported similar results.Multimodal analgesia uses a combination of delivery routes administered at variable time points to optimize outcomes in the treatment of acute pain.

Therefore, in this pilot study, the investigators are trying to evaluate safety and efficacy of preemptive multimodal analgesia compared with preemptive caudal analgesia and PCA morphine in pediatric cancer patient undergoing major abdominal surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Evaluation of Multimodal Preemptive Analgesia in Major Pediatric Abdominal Cancer Surgeries
Actual Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Nov 30, 2017
Actual Study Completion Date :
Nov 30, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Drug: Morphine

Morphine Group C (n=30) was the control group who received IV morphine in a dose of 0.1 mg/kg after induction of anesthesia

Drug: Morphine
patient controlled analgesia by morphine
Other Names:
  • Patient controlled analgesia
  • Active Comparator: Procedure/surgery:Caudal levobupivacaine

    In Caudal Group (n=30), patients were placed in the lateral position and received caudal epidural block after induction of anesthesia with levobupivacaine 0.125% , 1.1 ml/kg and morphine 0.02 mg/kg with maximum 20ml.

    Procedure: Caudal levobupivacaine
    an epidural injection of morphine and levobupivacaine through the caudal space
    Other Names:
  • Epidural
  • Active Comparator: Drug: Paracetamol and ketamine

    The patients of Multimodal Group (n=30) received paracetamol infusion 10 mg/kg over 10 minutes and ketamine 0.5 mg/kg IV bolus followed by ketorolac 1 mg/kg infusion over 10 minutes.

    Drug: Paracetamol and ketamine
    intravenous paracetamol and ketamine followed by ketorolac
    Other Names:
  • Multimodal
  • Outcome Measures

    Primary Outcome Measures

    1. Total morphine consumption [24 hours]

      Total morphine consumption during the postoperative 24 hours

    Secondary Outcome Measures

    1. Changes in VAS score for pain [Baseline and 6,12,18 and 24 hours]

      it is a scoring system from 0 to 100 where 0 means no pain while 100 represents maximum pain.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • were ASA I or II patients.

    • Aged between 5 and 12 years.

    • Both sexes.

    • Scheduled for major abdominal surgery with a midline incision.

    Exclusion Criteria:
    • included history of mental retardation or delayed development that may interfere with pain intensity assessment,

    • Known or suspected allergy to any administered drugs.

    • Active renal (creatinine clearance <50).

    • Hepatic (liver enzymes more than 10 folds).

    • Respiratory (SPO2 <92% on room air).

    • Cardiac disease (ejection fraction < 50%).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Anesthesia and Pain medicine.National Cancer Institute Cairo Egypt 11796

    Sponsors and Collaborators

    • National Cancer Institute, Egypt

    Investigators

    • Principal Investigator: Ehab H Shaker, MD, National Cancer Institute- Cairo University

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Ehab Hanafy Shaker, Clinical professor of Anesthesia ,Critical care and Pain medicine, National Cancer Institute, Egypt
    ClinicalTrials.gov Identifier:
    NCT03580980
    Other Study ID Numbers:
    • Ehab-Hossam.multi
    First Posted:
    Jul 10, 2018
    Last Update Posted:
    Jul 10, 2018
    Last Verified:
    Jul 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 10, 2018